Patent ID: 8906937

Claim:
A method of treating a Flavivirus infection in a subject, comprising administering to the subject a therapeutically effective amount of the compound of the following formula: or a pharmaceutically acceptable salt or prodrug thereof, wherein: R 1 is hydroxyl; R 2 , R 3 , R 4 , R 5 , and R 6 are each independently selected from hydrogen, hydroxyl, substituted or unsubstituted C 1-4 alkyl, substituted or unsubstituted C 1-4 heteroalkyl, substituted or unsubstituted C 2-4 alkenyl, substituted or unsubstituted C 2-4 heteroalkenyl, substituted or unsubstituted C 2-4 alkenyl, substituted or unsubstituted C 2-4 heteroalkynyl, or halogen; A is B is and R 7 is hydrogen.